BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6818713)

  • 1. HLA antigen associations in hypertrophic cardiomyopathy.
    Mourant AJ; Kafetz KM; Brigden WW; Awad J; D'Amaro J; Yeatman NW; Festenstein H
    Tissue Antigens; 1982 Nov; 20(5):389-93. PubMed ID: 6818713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DRW4 antigen linkage in patients with hypertrophic obstructive cardiomyopathy.
    Matsumori A; Kawai C; Wakabayashi A; Terasaki PI; Park MS; Sakurami T; Ueno Y
    Am Heart J; 1981 Jan; 101(1):14-6. PubMed ID: 6161533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human lymphocyte antigens in hypertrophic cardiomyopathy.
    Zezulka A; MacKintosh P; Jobson S; Lowry P; Shapiro LM
    Int J Cardiol; 1986 Aug; 12(2):193-202. PubMed ID: 3462161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR3 antigen linkage in patients with hypertrophic obstructive cardiomyopathy.
    Fiorito S; Autore C; Fragola PV; Purpura M; Cannata D; Sangiorgi M
    Am Heart J; 1986 Jan; 111(1):91-4. PubMed ID: 3484891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR antigen linkage in hypertrophic cardiomyopathy.
    Becque O; Herve P; Bassand JP; Bernard Y; Maurat JP
    Am Heart J; 1981 Oct; 102(4):806-8. PubMed ID: 6945040
    [No Abstract]   [Full Text] [Related]  

  • 6. [HLA antigens in patients with primary cardiomyopathy].
    Pietrzak M; Zebrowski A; Krzemińska-Pakuła M; Kaczmarek A; Miś J
    Kardiol Pol; 1988; 31(9):598-604. PubMed ID: 3244236
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA-DR2 antigen linkage in patients with apical hypertrophic cardiomyopathy in Japan.
    Kishimoto C; Takada H; Hiraoka Y; Suzaki M; Maruya E; Tomioka N
    Cardiology; 1996; 87(6):488-91. PubMed ID: 8904675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occurrence of HLA-antigens in patients with hypertrophic cardiomyopathy].
    Bodem R; Zipperle S; Ho A; Lenhard V
    Z Kardiol; 1982 Dec; 71(12):820-3. PubMed ID: 6962579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong association between an HLA-DR antigen and thyroid carcinoma.
    Panza N; Del Vecchio L; Maio M; De Felice M; Lombardi G; Minozzi M; Zappacosta S
    Tissue Antigens; 1982 Aug; 20(2):155-8. PubMed ID: 6814009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HLA-DRW grouping in obstructive myocardiopathy].
    Becqué O; Bernard Y; Bassand JP; Hervé P; Maurat JP
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1359-62. PubMed ID: 6439160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunogenetic study in hypertrophic cardiomyopathy.
    Gregor P; Ivasková E; Sajdlová H; Kupková L; Widimský P; Cervenka V
    Cor Vasa; 1991; 33(5):414-23. PubMed ID: 1810702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The human histocompatibility complex in hypertrophic cardiomyopathy].
    Pasalodos Pita J; Sancho Jaldón M; Trapiello González L; Grilo Reina A; Pareja Tallo E; Garrido Torrespuchol F; Vallés Belsue F
    Rev Esp Cardiol; 1981; 34(5):389-93. PubMed ID: 7199198
    [No Abstract]   [Full Text] [Related]  

  • 13. The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy.
    Shichi D; Kikkawa EF; Ota M; Katsuyama Y; Kimura A; Matsumori A; Kulski JK; Naruse TK; Inoko H
    Tissue Antigens; 2005 Sep; 66(3):200-8. PubMed ID: 16101831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic aspects of hypertrophic cardiomyopathy (familial studies and relation of HLA to obstructive hypertrophic cardiomyopathy)].
    Moiseev VS; Polianskaia IS; Iazdovskiĭ VV; Korovina EP; Guniia MG
    Ter Arkh; 1987; 59(8):82-5. PubMed ID: 3500526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy and HLA.
    Bloch A; Crittin J; Barras C; Jeannet M
    N Engl J Med; 1980 May; 302(18):1033. PubMed ID: 7189243
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunogenetic study in hypertrophic cardiomyopathy].
    Gregor P; Ivasková E; Sajdlová H; Kupková L; Widimský P; Cervenka V
    Vnitr Lek; 1992 May; 38(5):466-72. PubMed ID: 1509716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR specificities among Japanese with several autoimmune diseases.
    Sakurami T; Ueno Y; Iwaki Y; Park MS; Terasaki PI; Saji H
    Tissue Antigens; 1982 Feb; 19(2):129-33. PubMed ID: 6954729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunogenetics of SLE.
    Walport MJ; Black CM; Batchelor JR
    Clin Rheum Dis; 1982 Apr; 8(1):3-21. PubMed ID: 6811190
    [No Abstract]   [Full Text] [Related]  

  • 19. Histocompatibility. Influence of HLA-DR matching on renal graft survival. A Scandiatransplant report.
    Moen T; Berger L; Goyer K; Dahl O; Thorsby E
    Scand J Urol Nephrol Suppl; 1981; 64():30-7. PubMed ID: 6815792
    [No Abstract]   [Full Text] [Related]  

  • 20. HLA linkage vs association in hypertrophic cardiomyopathy. Evidence for the absence of an association in a heterogeneous Caucasian population.
    Gardin JM; Gottdiener JS; Radvany R; Maron BJ; Lesch M
    Chest; 1982 Apr; 81(4):466-72. PubMed ID: 7200000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.